M's strategic growth initiatives in semiconductors and aerospace may drive double-digit upside despite macro uncertainties.

Old Republic’s strong underwriting, niche focus, and resilient title business offer steady returns and inflation protection.

Biopharma giant Johnson & Johnson’s ($JNJ) stock hit new highs this year after reporting its Q2 results on July 16th, giving ...